173 related articles for article (PubMed ID: 33136534)
1. Diagnostic Value of Optical Coherence Tomography in the Early Diagnosis of Macular Complications in Chronic Vogt-Koyanagi-Harada Disease.
Agarwal M; Radosavljevic A; Patnaik G; Rishi E; Pichi F
Ocul Immunol Inflamm; 2022 May; 30(4):801-808. PubMed ID: 33136534
[TBL] [Abstract][Full Text] [Related]
2. Choroidal observations in Vogt-Koyanagi-Harada disease using high-penetration optical coherence tomography.
Nakai K; Gomi F; Ikuno Y; Yasuno Y; Nouchi T; Ohguro N; Nishida K
Graefes Arch Clin Exp Ophthalmol; 2012 Jul; 250(7):1089-95. PubMed ID: 22240936
[TBL] [Abstract][Full Text] [Related]
3. Retinal pigment epithelial changes in chronic Vogt-Koyanagi-Harada disease: fundus autofluorescence and spectral domain-optical coherence tomography findings.
Vasconcelos-Santos DV; Sohn EH; Sadda S; Rao NA
Retina; 2010 Jan; 30(1):33-41. PubMed ID: 20010321
[TBL] [Abstract][Full Text] [Related]
4. Diagnostic Function of 3D Optical Coherence Tomography Images in Diagnosis of Vogt-Koyanagi-Harada Disease at Acute Uveitis Stage.
Zhao GL; Li RZ; Pang YH; Wang XQ; Peng HJ; Wei JF; Zhou Z
Med Sci Monit; 2018 Feb; 24():687-697. PubMed ID: 29396390
[TBL] [Abstract][Full Text] [Related]
5. Correlation Between Hyperreflective Foci in the Choroid and Choroidal Discoloration in Vogt-Koyanagi-Harada Disease.
Kim YH; Togloom A; Oh J
Invest Ophthalmol Vis Sci; 2022 Aug; 63(9):27. PubMed ID: 36006654
[TBL] [Abstract][Full Text] [Related]
6. Predictive factors and adalimumab efficacy in managing chronic recurrence Vogt-Koyanagi-Harada disease.
Feng H; Chen W; Yang J; Kong H; Li H; He Y; Wang H
BMC Ophthalmol; 2024 Jun; 24(1):238. PubMed ID: 38849758
[TBL] [Abstract][Full Text] [Related]
7. Analysis of choroidal folds in acute Vogt-Koyanagi-Harada disease using high-penetration optical coherence tomography.
Tsuboi K; Nakai K; Iwahashi C; Gomi F; Ikuno Y; Nishida K
Graefes Arch Clin Exp Ophthalmol; 2015 Jun; 253(6):959-64. PubMed ID: 25663475
[TBL] [Abstract][Full Text] [Related]
8. Polarization-Sensitive Optical Coherence Tomographic Documentation of Choroidal Melanin Loss in Chronic Vogt-Koyanagi-Harada Disease.
Miura M; Makita S; Yasuno Y; Tsukahara R; Usui Y; Rao NA; Ikuno Y; Uematsu S; Agawa T; Iwasaki T; Goto H
Invest Ophthalmol Vis Sci; 2017 Sep; 58(11):4467-4476. PubMed ID: 28863408
[TBL] [Abstract][Full Text] [Related]
9. Multispectral image analysis in Vogt-Koyanagi-Harada disease.
Huang G; Peng J; Ye Z; Kijlstra A; Zhang D; Yang P
Acta Ophthalmol; 2018 Jun; 96(4):411-419. PubMed ID: 29220112
[TBL] [Abstract][Full Text] [Related]
10. Mycophenolate mofetil combined with systemic corticosteroids prevents progression to chronic recurrent inflammation and development of 'sunset glow fundus' in initial-onset acute uveitis associated with Vogt-Koyanagi-Harada disease.
Abu El-Asrar AM; Dosari M; Hemachandran S; Gikandi PW; Al-Muammar A
Acta Ophthalmol; 2017 Feb; 95(1):85-90. PubMed ID: 27535102
[TBL] [Abstract][Full Text] [Related]
11. Retinal vessel oxygen saturation is affected in uveitis associated with Vogt-Koyanagi-Harada disease.
Abu El-Asrar AM; AlBloushi AF; Gikandi PW; Hardarson SH; Stefánsson E
Br J Ophthalmol; 2019 Dec; 103(12):1695-1699. PubMed ID: 30798260
[TBL] [Abstract][Full Text] [Related]
12. Objective evaluation of choroidal melanin loss in patients with Vogt-Koyanagi-Harada disease using polarization-sensitive optical coherence tomography.
Miura M; Makita S; Yasuno Y; Azuma S; Mino T; Yamaguchi T; Iwasaki T; Nemoto R; Shimizu H; Goto H
Sci Rep; 2022 Mar; 12(1):3526. PubMed ID: 35241784
[TBL] [Abstract][Full Text] [Related]
13. The effect on choroidal changes of the route of systemic corticosteroids in acute Vogt-Koyanagi-Harada disease.
Park UC; Cho IH; Lee EK; Yu HG
Graefes Arch Clin Exp Ophthalmol; 2017 Jun; 255(6):1203-1211. PubMed ID: 28382438
[TBL] [Abstract][Full Text] [Related]
14. Vogt-Koyanagi-Harada disease.
O'Keefe GA; Rao NA
Surv Ophthalmol; 2017; 62(1):1-25. PubMed ID: 27241814
[TBL] [Abstract][Full Text] [Related]
15. A clinical grading system based on ultra-wide field retinal imaging for sunset glow fundus in Vogt-Koyanagi-Harada disease.
Lee EK; Lee SY; Yu HG
Graefes Arch Clin Exp Ophthalmol; 2015 Mar; 253(3):359-68. PubMed ID: 25017008
[TBL] [Abstract][Full Text] [Related]
16. Depigmented atrophic lesions in sunset glow fundi of Vogt-Koyanagi-Harada disease.
Inomata H; Rao NA
Am J Ophthalmol; 2001 May; 131(5):607-14. PubMed ID: 11336935
[TBL] [Abstract][Full Text] [Related]
17. Clinical and multimodal imaging characteristics of acute Vogt-Koyanagi-Harada disease unassociated with clinically evident exudative retinal detachment.
Attia S; Khochtali S; Kahloun R; Ammous D; Jelliti B; Ben Yahia S; Zaouali S; Khairallah M
Int Ophthalmol; 2016 Feb; 36(1):37-44. PubMed ID: 25939987
[TBL] [Abstract][Full Text] [Related]
18. Incidence, Risk Factors and Surgical Outcomes of Cataract among Patients with Vogt-Koyanagi-Harada Disease.
AlBloushi AF; Alfawaz AM; AlZaid A; Alsalamah AK; Gikandi PW; Abu El-Asrar AM
Ocul Immunol Inflamm; 2021 Jan; 29(1):128-136. PubMed ID: 31638886
[No Abstract] [Full Text] [Related]
19. The Role of Widefield Optical Coherence Tomography Angiography in the Diagnosis and Management of Acute Vogt-Koyanagi-Harada Disease.
Ding X; Shu Q; Bai X; Chang Q; Xu G; Chen L
Ocul Immunol Inflamm; 2024 May; 32(4):391-401. PubMed ID: 36856749
[TBL] [Abstract][Full Text] [Related]
20. Acquired myopia in Vogt-Koyanagi-Harada disease.
Takahashi H; Takase H; Terada Y; Mochizuki M; Ohno-Matsui K
Int Ophthalmol; 2019 Mar; 39(3):521-531. PubMed ID: 29397539
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
